Filter Results
:
(89)
Show Results For
-
All HBS Web
(159)
- News (43)
- Research (89)
- Events (1)
- Multimedia (5)
- Faculty Publications (54)
Show Results For
-
All HBS Web
(159)
- News (43)
- Research (89)
- Events (1)
- Multimedia (5)
- Faculty Publications (54)
←
Page 5 of
89
Results
Sort by
- 29 Nov 2004
- Research & Ideas
Caves, Clusters, and Weak Ties: The Six Degrees World of Inventors
the norms of science. It's an ironic and fascinating time to study technology, science, and invention. In some ways the processes of invention in firms are moving towards an open science model. For example, Novartis and the Broad...
View Details
- 26 Jan 2004
- Research & Ideas
What Developing-World Companies Teach Us About Innovation
goal is to reach 800,000 more within five years. Innovate Around—rather Than Through—the Technology Companies such as Samsung or Novartis can drive innovation from their R&D labs, continually translating scientific breakthroughs into...
View Details
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
of (systemic) invention. The opportunity, therefore, is to start reinventing the future health care delivery system that will sustainably deliver prevention and sick care in a post-COVID world. Amy C. Edmondson (@AmyCEdmondson) is the View Details
Keywords:
by Danielle Kost
- 26 Feb 2007
- Research & Ideas
The Power of the Noncompete Clause
injunction based on the Nuance engineers' noncompetes. The flip side of the coin is that employers can exploit these differences by locating in areas such as Silicon Valley where noncompetes do not block one's ability to recruit talent. For example, one legal scholar...
View Details
Keywords:
by Martha Lagace
- 11 Dec 2007
- First Look
First Look: December 11, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=808089 Valuation at Novartis Harvard Business School Case 108-041 An abstract is not available for this case. Purchase this case:...
View Details
Keywords:
Martha Lagace